(MENAFN- PR Newswire)
PORTAGE, Mich., USA, Nov. 14, 2024 /PRNewswire/ -- Stryker
(NYSE:SYK ), a global leader in medical technologies, announced its launch of the next generation of SurgiCount+ within its sponge management portfolio. Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals.
SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment.
SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment.
SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment.
>1. Hoyert DL. Maternal mortality rates in the United States, 2021. NCHS Health E-Stats. 2023. DOI: :124678
2. Callaghan, W.M., Creanga, A.A. and Kuklina, E.V. (2012) "Severe maternal morbidity among delivery and postpartum hospitalizations in the United States," Obstetrics & Gynecology,120(5), pp. 1029–1036. doi:10.1097/aog.0b013e31826d60c5.
3. Building U.S. Capacity to Review and Prevent Maternal Deaths. (2018). Report from nine maternal mortality review committees.
4. Gawande, A. A., Studdert, D. M., Orav, E. J., Brennan, T. A., & Zinner, M. J. (2003). Risk factors for retained instruments and sponges after surgery. The New England Journal of Medicine, 348(3), 229–235.
5. Double-blinded survey of 154 Operating Room Nurses from 154 different facilities across the United States. Data on file internally. Conducted August 2020.
6. Rotenstein, L.S., Brown, R., Sinsky, C.
et al.
The Association of Work Overload with Burnout and Intent to Leave the Job Across the Healthcare Workforce During COVID-19.
J GEN INTERN MED
38, 1920–1927 (2023).
SOURCE Stryker
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE?
440k+
Newsrooms &
Influencers
9k+
Digital Media
Outlets
270k+
Journalists
Opted In
GET STARTED
MENAFN14112024003732001241ID1108886701
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.